Skip to content

Drug interactions

Elacestrant + Sirolimus

Severity: Moderate

Elacestrant and Sirolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elacestrant may inhibit intestinal P-glycoprotein and could increase sirolimus absorption and exposure. The clinical effect is predicted rather than well documented, but sirolimus has a narrow therapeutic range.

What this interaction means in plain words

Elacestrant and Sirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Elacestrant belongs to Oncology; Sirolimus belongs to Miscellaneous.

Evidence level: Low

Why it happens

Elacestrant inhibits P-glycoprotein efflux, potentially increasing sirolimus bioavailability.

What to do

Monitor sirolimus trough levels when elacestrant is started or stopped and reduce the sirolimus dose if concentrations are elevated.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elacestrant and Sirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elacestrant with Sirolimus?

MediHelp rates the interaction as moderate. Elacestrant and Sirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Elacestrant may inhibit intestinal P-glycoprotein and could increase sirolimus absorption and exposure. The clinical effect is predicted rather than well documented, but sirolimus has a narrow therapeutic range.

How serious is the interaction between Elacestrant and Sirolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor sirolimus trough levels when elacestrant is started or stopped and reduce the sirolimus dose if concentrations are elevated.

What other medicines interact with Sirolimus?

MediHelp also lists interactions of Sirolimus with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Sirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in